Advances in emerging therapies

Stroke

Volumn 40, Issue 5, 2009, Pages

  Higgins, Peter ^a,b   Lees, Kennedy R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Advances; Emerging therapies; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CITICOLINE; CLOPIDOGREL; DABIGATRAN; DIPYRIDAMOLE; DISUFENTON SODIUM; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; IDRAPARINUX; INSULIN; NORPHENAZONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TENECTEPLASE; WARFARIN; XIMELAGATRAN; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

BLEEDING; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; HYPERGLYCEMIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; MORTALITY; NEUROIMAGING; NEUROPROTECTION; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; SHORT SURVEY; STROKE; REVIEW;

FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; STROKE; THROMBOLYTIC THERAPY;

EID: 65549119553     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.544544     Document Type: Short Survey

References (14)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; for the ECASS Investigators. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med. 2008;359:1317-1329.
2. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, Risto Roine O, Toni D, Lees KR; for the SITS investigators Thrombolysis with alteplase 3-4 5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372:1303-1309.
3. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurology. 2008;7:299-309.
4. Molina CA, Ribo M, Rubiera M, Santamarina E, Delgado-Mederos R, Maisterra O, Delgado P, Dinia L, Pontes O, Montaner J, Alvarez-Sabin J. TNK Induces Faster MCA Recanalisation and leads to Better Short-and Long-term Clinical Outcome Than Native TPA. The TNK-TPA Reper-fusion Stroke Study (abstract). Stroke. 2008;39:563.
5. Eggers J, Konig IR, Koch B, Handler G, Seidel G. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plas-minogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke. 2008;39:1470-1475.
6. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PCAJ, De Keyser J, Luijckx G. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Arch Neurol. 2008;65:607-611.
7. Adams HP Jr. Effron MB. Torner J. Davalos A. Frayne J. Teal P Leclerc J Oemar B Padgett L Barnathan ES Hacke W; AbESTT-II Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II) Stroke. 2008;39:87-99.
8. Pancioli AM, Broderick J, Brott T Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ; for the CLEAR Trial Investigators. The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke. The CLEAR Stroke Trial. Stroke. 2008; 39:3268-3276.
9. Sacco RL, Diener H, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BPL, Chen S, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon B, for the PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
10. The Amadeus Investigators. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet. 2008; 371:315-321.
11. Ford, Gary A. MD; Choy, Anna Maria MD; Deedwania, Prakash MD; Karalis, Dean G MD; Lindholm, Carl-Johan MD; Pluta, Wladyslaw MD; Frison, Lars PhD; Olsson, S Bertil MD; on behalf of the SPORTIF III, V Investigators. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V trials Stroke. 2008;38:2965-2971.
12. Bruno A, Kent TA, Coull BM, Shanker RR, Saha C, Becker KJ, Kissela BM, Williams LS. Treatment of Hyperglycaemia In Ischemic Stroke (THIS): a randomised pilot trial. Stroke. 2008;39:384-389.
13. Schabitz WR, Laage R, Schwab S, Schneider D, Hamann G, Rosenkranz M, Veltkamp R, Fisher M, Grotta J, Hacke W, Shneider A; for the AXIS study group. AX200 (G-CSF) for the Treatment of Acute Ishcemic Stroke (AXIS) (abstract). Stroke. 2008;39:561.
14. Ohta Y, Fukushima T, Takamatsu K, Ikegami S, Takeda I, Ota T, Goto K. Efficacy of a free radical scavenger, edaravone, on lacunar infarction (abstract). Stroke. 2008;39:612.